Duration of Response: Clinical Trials

1 trial for Duration of Response, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Duration of Response: new trials by email Literature Review of Duration of Response trials Research Report on Duration of Response

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks
Low, non-weight based dose of Dexamethasone and Dexmedetomidine in peripheral nerve blocks, Ropivacaine with low, non weight based Dexamethasone additive - Postoperative Pain, Nausea and Vomiting, Postoperative
Phase 1 / Phase 2Active not recruitingUniversity of Arizona1002024-10-102026-02-13

Narrower conditions

Constipation (1)  ·  Dizziness (1)  ·  Pain, Postoperative (1)  ·  Postoperative Nausea and Vomiting (1)

Broader conditions

Nausea (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Postoperative Complications (1)  ·  Sensation Disorders (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)  ·  Vomiting (1)

Interventions

Dexamethasone (1)  ·  Dexmedetomidine (1)  ·  Ropivacaine (1)

Sponsors

University of Arizona (1)

Countries

United States (1)

Top investigators

Ronald Tang, MD (1)